Understanding the mechanisms regulating human mammary epithelium requires knowledge of the cellular constituents of this tissue. Different and partially contradictory definitions and concepts describing the cellular hierarchy of mammary epithelium have been proposed, including our studies of keratins K5 and/or K14 as markers of progenitor cells. Furthermore, we and others have suggested that the p53 homolog p63 is a marker of human breast epithelial stem cells. In this investigation, we expand our previous studies by testing whether immunohistochemical staining with monospecific antikeratin antibodies in combination with an antibody against the stem cell marker p63 might help refine the different morphologic phenotypes in normal breast epithelium. We used in situ multilabel staining for p63, different keratins, the myoepithelial marker smooth muscle actin (SMA), the estrogen receptor (ER), and Ki67 to dissect and quantify the cellular components of 16 normal pre-and postmenopausal human breast epithelial tissue samples at the single-cell level. Importantly, we confirm the existence of K5+ only cells and suggest that they, in contrast to the current view, are key luminal precursor cells from which K8/18+ progeny cells evolve. These cells are further modified by the expression of ER and Ki67. We have also identified a population of p63+K5+ cells that are only found in nipple ducts. Based on our findings, we propose a new concept of the cellular hierarchy of human breast epithelium, including K5 luminal lineage progenitors throughout the ductal-lobular axis and p63+K5+ progenitors confined to the nipple ducts.
Introduction
Knowledge of the complexity of human adult mammary gland epithelium is a prerequisite for understanding normal physiological regeneration and to develop concepts of abnormal proliferative disease. Recent studies using cell sorting (CD49f, EpCAM), Hoechst 33342 staining, cell fate mapping experiments in transgenic mice, in vitro and transplantation assays, multicolor immunofluorescence stainings, and molecular analyses have generated partially contradicting models of the breast epithelium (Supplementary Figure 1 ). Several of these studies, have identified subpopulations of bipotent mammary cells in human and mouse breast epithelia with "stemness" features that are immunohistochemically strongly positive for basal keratins K5 and/or K14 [1, 6, 13] . Other studies have proposed a ductal stem cell zone characterized by the accumulation of K14+K19+ cells [8] or a subpopulation of ER+ cells [29, 30] . Finally, based on molecular cell tracing experiments, a model has been proposed, postulating the existence of unipotent myoepithelial and luminal stem cells in the mouse mammary epithelium [22] . More recently, the stem cell marker p63 has been suggested as a marker of human breast epithelial stem cells [3] . This is in line with our findings, that human breast epithelium contains p63+K5+ cells [31] .
Here we expand on our previous studies [1, 31] to further test the hypothesis that K5+ and/or p63+K5+ progenitors play a role in the maintenance of human breast epithelium. We quantitatively evaluated the expression of p63 and basal keratins K5 and K14 as phenotypic markers of stem-/progenitor cells in the mammary cell hierarchy. We used multicolor stainings to study the stem cell markers p63 [32] [33] [34] [35] [36] [37] [38] , K5, and K14 [1, 39] , the differentiation markers and luminal keratins K18, K8/18, and K19 [1, [40] [41] [42] [43] [44] [45] [46] , and the myoepithelial lineage markers smooth muscle actin (SMA) [47, 48] , smooth muscle myosin heavy chain [49] , calponin [50, 51] , and CD10 [47, [52] [53] [54] [55] . We also evaluated the functional markers estrogen receptor (ER)-alpha [5, 23, 29, [56] [57] [58] [59] [60] [61] and Ki67 [62] [63] [64] [65] [66] . Based on our findings, we propose a modified concept of the cellular hierarchy of human breast epithelium, including K5+ luminal lineage progenitor cells in the ductal-lobular axis and p63+K5+ progenitor cells confined to nipple ducts.
Material and methods

Case selection
Histologically normal breast tissue samples were obtained from 16 women aged 27-80 years (8 premenopausal aged 27-42 years, and 8 postmenopausal aged 52-80 years) who were undergoing surgery for breast carcinoma, fibroadenoma, or reduction mammoplasty, under informed patient consent. The samples were retrieved from the archives of the Department of Pathology of the University of Muenster (WB) and the Institute of Pathology of the Friedrich Bonfoeffer Clinic in Neubrandenburg. All tissues were immediately formalin-fixed and paraffin-embedded. Only grossly, histologically, and immunohistochemically normal tissues were included. The samples were taken at a distance of at least 3 cm from the site of the tumor. Samples with any type of epithelial hyperplasia (blunt duct adenosis, columnar cell change/hyperplasia, usual ductal hyperplasia) or intraepithelial atypia (flat epithelial atypia, atypical ductal hyperplasia, ductal carcinoma in situ, lobular neoplasia), as defined by the current WHO classification of breast tumors [67] , were excluded. Parity history, menstrual cycle status, use of oral contraceptives, and hormone replacement therapy were not included in this study.
Bright-field microscopy
The primary antibodies used are shown in Table 1 . For bright-field microscopy, primary antibodies were detected using the Dako LSAB REAL Detection System (Naphthol phosphate/Fast Red, no. K5005; Dako Corporation, Hamburg, Germany) or AmpliStain™ Horseradish Peroxidase (HRP) conjugates (SDT GmbH, Baesweiler, Germany) according to the manufacturers' instructions [68] . The HRP label was visualized using a 3,3′-diaminobenzidine (DAB) substrate kit (Vector Laboratories, Burlingame, CA, USA).
In situ multicolor staining
Triple immunostaining was performed using antibodies against p63, basal keratins K5 and K14, luminal keratins K18-fluorescein isothiocyanate (FITC), K8/18, K19, SMA, calponin, and CD10, and the functional markers ER and Ki67 (compare Fig. 1 ). As double staining with the three [69] . The reporter molecule was either the fluorophore Cy3 or biotin. The latter was visualized using fluorophore-labeled streptavidin. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI, 5 µg/ml in phosphate-buffered saline [PBS]) for 15 s, and the sections were then mounted using VectaShield (Vector Laboratories, Burlingame, USA).
Image acquisition
Immunostained sections were examined with a Zeiss microscope (Axio Imager Z1). Images were captured with an AxioCam black and white digital microscope camera. The AxioVision image processing program (Carl Zeiss Vision, Germany) allows fluorophores to be visualized in any artificial color. For example, in some figures, we chose the yellow color for the red fluorophore Cy3 because the other two labels were green and red. Far-red fluorescence (Alexa 647) was also presented in different artificial colors, although usually in pink (magenta).
Quantification of immunohistochemical and multicolor immunofluorescence staining
The different p63 and keratin epithelial phenotypes and their functional features (Ki67 and ER expression) were quantified and expressed as percentages of the total number of cells counted. Photographs were randomly acquired using a highpower lens and the appropriate filter sets in succession for the visualization of DAPI, Cy5 or Alexa Fluor 647, Cy3, and FITC or Alexa Fluor 488 to assess the presence of these antigens in single-labeled cells. Positively stained cells were determined by counting cells within at least 10 fields of view per slide using a ×40 objective (700 × 500 µm). Quantification of the cell content was performed using a counting program incorporated in the AxioVision software. Ten merged images per triple staining and case were taken using the splitter display of the AxioVision image processing software (Carl Zeiss Vision, Germany) to analyze and count cell by cell at higher magnification ( Fig. 1) .
Results
Immunohistology
Immunohistochemically, nipple ducts are characterized by a basal (myoepithelial) layer positive for p63, basal keratins 
Nipple ducts
Triple immunofluorescence staining revealed a multitude of multi-colored cells within the nipple ducts (Supplementary Figure 4) . In terms of keratin expression patterns, three different cell types could be robustly distinguished in the luminal layer ( These cells expressed neither keratins K8/18 nor the myoepithelial marker SMA. Some of these p63+/K5/14+ cells seemed to be restricted to the luminal layer with a transition to K5-only-positive cells (Fig. 3 ), thus showing a striking similarity to the cellular constituents of salivary gland excretory ducts (Supplementary Figure 13) . The quantification of the luminal epithelium of the breast nipple ducts of pre-and postmenopausal women are shown in Tables 2 and  3 . Concerning the K5(K14+/−) cells and p63+K5+ progenitors in the ductal-lobular axis and the ER-expression pattern in nipple ducts and lobules, we found no differences between fibroadenoma or carcinoma bearing breasts or samples obtained from reduction mammoplasty. Importantly, quantification of a total of 10,331 cells across all cases revealed a small number of K5-only-positive cells (average 5.1%), approximately two-thirds of K5 and K8/18 coexpressing intermediary cells (average 63.47%), and onethird of K8/18-only-positive cells (average 31.4%) ( Fig. 4a ; Table 2 ). Less than an average of 1% of the cells expressed p63 and K5/14 and lacked K8/18 and SMA (Table 2) .
About one-fifth (average 20.8%) of the cells expressed ER, and nearly all of these co-expressed K8/18. Only a small percentage of ER+ cells co-expressed K5 (Fig. 5a , Table 3 ). Analyses of the expression of Ki67 and ER revealed double staining of Ki67 and ER in 2.3% and 10.6% of Ki67+ cells in premenopausal and postmenopausal females, respectively (Fig. 5b, Supplementary  Figure 14 , Table 4 ). Tables 2 and 3 . Overall, quantification of a total of 10,362 luminal lobular cells revealed that a small number of cells expressed K5 only (average 2.1%), approximately one-third co-expressed K5 and K8/18 (average 30.92%), and nearly two-thirds expressed only the glandular keratins K8/18 (average 66.97%) (Fig. 4b and Table 2 ). In contrast to the nipple ducts, the p63+ cells in TDLUs were confined to the myoepithelial cell layer (Fig. 7a) .
Analysis of the ER status revealed nearly one-third of ER + cells (average 29.4%), including mainly ER and K18 coexpressing cells (average 28.9%) and a minor fraction (0.5%) of ER+K5+K18+ cells (Table 3) . Quantification of Ki67 and ER double stainings revealed that 3.3 and 17.03% of Ki67+ cells co-expressed Ki67 and ER in premenopausal and postmenopausal women, respectively ( Fig. 7b and Table 4 ).
Discussion
Here we present a modified concept of the cellular organization of normal human breast epithelium (Fig. 8) compared to that envisioned in most current concepts (Supplementary Figure 1) . Importantly, we have identified a discrete population of K5+(K14+/−) progenitor cells which, in contrast to the current view, are regarded as part of a larger contiguous, tightly linked cell population in the luminal layer of both nipple ducts and lobules. Glandular differentiation involves the sequential modulation of these cells with a shift from K5+(K14+/−) cells via K5+K8/18+ intermediary cells to K8/18+ glandular cells, as shown in our working model in Fig. 8 . Our findings are in line with the observations of Lim et al. [3] who identified a CD49f pos (alpha-6 integrin)/EpCAM pos subpopulation of luminalrestricted progenitor cells characterized immunohistochemically by the expression of K5/6 (49.9%), K8/18 (91%), MUC1 (80%), and ER (28%), but lacking p63 (Fig. 9) . In vitro studies, showed that these cells generated only homogeneous glandular structures. This study is notable because it emphasizes our observations that lineage identity cannot be based solely on the presence or absence of basal keratins K5 and/or K14. For example, K5+ (and/or K14+) cells co-expressing p63 and SMA clearly belong to the myoepithelial/basal lineage [70, 71] , whereas K5+(K14 +/−) only cells and K5+(K14+/−)K8/18+ cells, according to our observations, belong to the luminal lineage.
We have also identified a small population of p63+K5/ 14+ precursor cells residing at the interface between the myoepithelial and luminal cell layers of the human nipple duct epithelium. These cells seem to be the least differentiated cells expressing neither the luminal keratins K8/18 nor the myoepithelial marker SMA. Based on previous data, we suggest that these cells may undergo a transition from their original p63+K5/14+ precursor state to a K5+K14 +/− luminal precursor state, and that they also may generate the p63+ SMA+ myoepithelial cells [3] . For example, , and K5/6 (52%), and lacking K8/18 (2.3%) and ER (0.2%). In transplantation assays, only this subpopulation of human epithelial breast cells showed bilinear differentiation potential [3] (cf. Fig. 8) . Furthermore, the view that p63 may play a role in breast epithelium is supported by recent studies showing that Notch signaling downregulates p63 expression prior to luminal lineage commitment [72] . Similarly, Notch inactivation in mouse mammary glands leads to accumulation of immature p63+K5+ cells (even in luminal position) and K14+K18+ cells [73] . Finally, the crucial role of p63 in the maintenance of epithelium has also been demonstrated at several other anatomical sites, including, for example, the thymus, epidermis, upper airways, and prostate [36, 37, [74] [75] [76] [77] [78] [79] [80] .
In the present study, the average ER expression level of lobular cells was higher than that in nipple ducts. In agreement with the literature, the level of ER expression in the lobular epithelium of postmenopausal women (38.4%) was much higher than in premenopausal women (19.9%). Among the different luminal phenotypes, we found ERalpha expression in K8/18+ differentiated cells, whereas only a limited number of K5+K8/18+ progenitor cells showed ER-positivity. The significance of ER expression in these progenitors remains unclear. Similarly, and in agreement with the literature, increased levels of Ki67+ER+ cells were observed in TDLUs of postmenopausal as compared to premenopausal women [59, 81] .
The present observations have several important implications. Thus, our study indicates that the current view of K8/18+ luminal cells vs. K5/14+ basal/myoepithelial cells as basic biological constituents of normal human breast epithelium and their tumors [82, 83] needs to be modified. The finding of K5+K14+/− progenitors within the luminal layer has important conceptual implications not only for our understanding of normal regeneration. For example, a subset of basal-type breast carcinomas may, as suggested by Lim et al. [3] , be better classified as the luminal progenitor subtype. Furthermore, the finding of rare p63+K5+ tumors, such as, for example adenoid cystic carcinoma and syringomatous tumors/low-grade adenosquamous carcinoma of the breast, suggests the existence of a corresponding p63 +K5+ normal cell type as previously discussed [84] [85] [86] . With this conceptual knowledge, we may now approach the question of developmental relationships between the cell types in normal breast epithelium and their counterparts in proliferative breast diseases [87] . It is plausible that the diversity of phenotypic and functional characteristics of breast tumors may emerge from a combination of cell of origin features and specific acquired genetic/epigenetic changes of these cells during tumorigenesis [87] [88] [89] [90] [91] .
Our model does not fully comply with some of the previously published data. We and others have proposed that K5+ and/or K14+ cells are bipotent progenitors in the mammary epithelium [1, 6, 92] . This concept has been based on K5+ and/or K14+ cells as the least differentiated cells that differentiate toward glandular epithelial or myoepithelial end cells. However, as discussed above, the introduction of p63 as an important biomarker in breast epithelium questions the view of K5+K14+/− cells as [7, 8] , who described a ductal stem cell zone characterized by accumulation of K14+K19+ stem cells. Although, we can confirm the existence of K14+K19+ cells in the luminal epithelium (cf. Supplementary Figure 7) , we interpret them as intermediary glandular cells identical to K5+K8/18+ cells. Finally, one study using a genetic lineage-tracing approach in adult mice [6] suggested the existence of unipotent K14+ basal and K8/18+ luminal progenitors and noted that K14+ cells do not contribute to the luminal lineage [22] . In the present study, we clearly show that K5+K14+/− cells are constituents of the human luminal breast epithelium and should therefore be interpreted in the context of luminal cell differentiation [3] .
A limitation of this study is that the number of cases studied is relatively small. This is due to the fact that the study and methods used are laborious and time consuming since the quantification is done at the single-cell level on merged and single-channel images and there are no high-throughput techniques available. However, further developments in this area are needed since recent studies have indicated that the cellular "makeup" of the breast epithelium may have an important impact on breast cancer development [3] .
In summary, we provide new evidence for the existence of K5+K14+/− luminal progenitors from which glandular progeny cells evolve. We also demonstrate the presence of a small subpopulation of p63+K5/14+ bipotent progenitors confined to the nipple ducts. Moreover, we show that ER expression is associated with differentiated glandular cells and is only rarely observed in progenitors. Based on these findings, we propose a new, modified model of the hierarchical organization of breast ducts and lobules. Future refinements of molecular breast epithelial signatures may provide new important insights into the definition and regulation of stem/progenitor cells in normal and diseased breast tissues.
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